Submaximal Decision Theory and Health Resource Conservation: The Example of Congestive Heart Failure by McArthur, Kara & Dacso, Clifford C.
K. McArthur & C. C. Dacso / Californian Journal of Health Promotion 2007, Volume 5, Sp Iss (Health Disparities & Social Justice), 41-47 
 
 
Submaximal Decision Theory and Health Resource Conservation: The Example of 
Congestive Heart Failure 
 
Kara McArthur and Clifford C. Dacso 
 
University of Houston 
 
Abstract 
The challenge of eliminating disparities in chronic illness in the United States is hampered by the 
diversity of the epidemiology of the chronic conditions themselves, and by the individuality of the 
communities and patients affected by them. This article outlines some of the ways in which the 
complexity of chronic illness in underserved communities in the United States limits the data and the 
strategies available to clinicians and patients. We then present the example of chronic heart failure (CHF) 
to illustrate a possible solution that we are developing for supporting underserved patients’ self-
management of chronic illness: individualized health care (through “personal normals” derived from the 
patient’s own clinical history combined with population-based data), and distributed health care (point of 
care through wireless biosensors and community health workers). We present some of the possible 
barriers to the implementation of the model. Conclusion: we believe that this approach is a pathway to 
empowering CHF patients in underserved communities. Further research is necessary to test the clinical 
viability of the model and the acceptability of the model for patients, physicians, and families. 
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Introduction: The Challenge of Chronic 
Disease 
Chronic disease is the health challenge of the 
21st century. Today, any improvement in the 
health status of the United States depends upon 
the successful prevention and control of chronic 
diseases in all populations. According to the 
National Center for Chronic Disease Prevention 
and Health Promotion (National Center for 
Chronic Disease Prevention and Health 
Promotion [NCCDPHP], 2007), chronic 
conditions are the leading causes of death and 
disability in the United States. Chronic illnesses 
such as heart disease, COPD, and diabetes 
account for seven out of every ten deaths each 
year and affect the quality of life of 90 million 
Americans. Chronic illness seriously limits the 
activity of one in ten Americans, or 25 million 
people (NCCDPHP, 2005). As the U.S. 
population ages, these numbers are expected to 
increase, as are the attendant costs (78% of total 
health spending in 2000) (Anderson, 2004). 
 
Chronic illness affects different populations 
differently. The examples of racial, ethnic, 
geographic, financial, and sex differences in 
access, utilization, and outcome are well-
documented (Centers for Disease Control and 
Prevention, Office of Minority Health, n.d.; 
Hadley, Cunningham & Hargrave, 2006). In 
fact, the differences between and among 
populations are so numerous that any attempt to 
address disparities in chronic illness prevention 
and control in a culturally appropriate and 
effective manner is necessarily highly complex 
and fraught with uncertainty. 
 
Cancer and Chronic Disease 
Management 
The NCCDPHP lists cancer as a chronic 
condition and, certainly, cancer is a chronic 
systemic disease with local manifestations. 
Cancer also shares causes with other chronic 
conditions (behavioral, genetic, environmental). 
 
For the purposes of this analysis, however, 
cancer is a unique case that is excluded from the 
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discussion because it is not a single disease, and 
because its lifelong management differs from 
that of other chronic conditions. Most cancer 
intervention programs rightly stress prevention, 
early detection, and treatment, rather than 
continuous management. The medical 
management of cancers is episodic and intense 
and although the person living with cancer lives 
with it at all times, his or her need of the medical 
care system generally comes in defined quanta. 
In contrast, for example, a patient with diabetes 
is completely dependent upon daily, even 
hourly, disease management (generally self-
management). 
 
Thus, this paper focuses upon chronic illnesses 
such as coronary artery disease/stroke, CHF, 
COPD/asthma, type 2 diabetes/metabolic 
syndrome, and depression. How these conditions 
are managed in the “real world” manifests the 
problems and the disparities in the U.S. health 
care system (Trans-HHS Cancer Health 
Disparities Progress Review Group, 2004, p. 8). 
 
How Chronic Disease is Cared for Reflects 
the General Health Status and Disparities in 
a Community 
People with chronic diseases are likely to engage 
with the health care system to a greater extent 
and for longer times than most other people. In 
the course of their illness (and, for some, their 
entire lives), most people with chronic 
conditions will experience the gamut of general 
medical visits, diagnostic tests, pharmaceutical 
prescriptions, consultations with specialists, 
visits to emergency rooms and hospitals, and 
(possibly) procedures. Because chronic disease 
patients and their families experience the health 
care system at almost every level, how 
successfully the system works for them can be 
viewed as a reflection of how well the system 
works for everyone—for the powerful and 
efficacious as well as for the underserved and 
under-resourced. 
 
On a macro level, how well does the current 
system serve the chronically ill? Tens of surveys 
and audits have shown that large numbers of 
chronically ill people are not receiving high-
quality care, have problems controlling their 
conditions, and are not satisfied with their 
medical care (Bodenheimer, Wagner, & 
Grumbach, 2002; Casalino, 2005; Wagner, 
1997; Wennberg, Fisher, Baker, Sharp, & 
Bronner, 2005). While consistent management 
of chronic illness has the potential to reduce 
complications, improve patients’ quality of life, 
and reduce the cost of care, in reality chronic 
disease sufferers tend to receive episodic, crisis-
oriented, uncoordinated care, with sporadic 
follow-up and inadequate support to manage 
their illnesses themselves. The U.S. health care 
system privileges acute, office- and hospital-
based care over preventive care and patient self-
management.  It is a “disease care system” not a 
health care system. 
 
At a micro level, chronic disease allows one to 
biopsy the health status and disparities of our 
communities themselves. According to the 
NCCDPHP, chronic disease management 
requires prevention, access to care, continuity of 
care, patient education, and support for self-
management (NCCDPHP, 2006). The National 
Healthcare Disparities Report shows that, at 
every level of this continuum, disparities are 
systemic, and affect people by virtue of their 
race, ethnicity, income, education, place of 
residence, and age (Agency for Healthcare 
Research and Quality [AHRQ], 2003). Even 
more troubling, racial and ethnic minority 
patients receive lower-quality care — even when 
controlling for income and insurance coverage 
(Institute of Medicine, 2003). Finally, in the area 
of support for self-management, an essential to 
controlling chronic disease, the Disparities 
Report demonstrates that disparities are 
exacerbated by problems underserved patients 
encounter communicating with their providers 
and accessing information about their conditions 
(Agency for Healthcare Research and Quality 
[AHRQ], pp. 120-127). 
 
Individualized Medicine 
Disparate Conditions 
When dealing with the variety of chronic illness 
in the United States today and the diverse needs 
of underserved populations, traditional 
epidemiological strategies are blunt weapons. 
While the causes of chronic illness can be 
reduced to a relatively short list — diet, physical 
inactivity, tobacco use, environment, and 
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genetics — addressing the reality of chronic 
disease is far more complicated. Describing, 
understanding and, ultimately, affecting the 
pandemic of chronic disorders is considerably 
complex because each chronic illness and 
population has its own epidemiology, and the 
scientific datasets on specific health conditions 
can be unwieldy, contradictory, uneven in 
quality, or simply not available. In addition, 
chronic conditions often occur jointly (e.g., 
diabetes and hypertension), with unknown 
conjoint effects. 
 
Disparate Populations 
Significant variations in risk factors and chronic 
conditions among underserved populations 
indicate that chronic-disease management 
practices should “vary among different 
racial/ethnic groups, and even among 
communities within each group,” and that 
culturally sensitive treatment programs should 
be tailored to meet community-specific needs 
(Liao, Tucker, & Giles, 2004). Thus, meeting 
the challenge of chronic illness management in 
the United States requires acknowledging the 
fact that societal-level data must be balanced by 
individual-level approaches that originate in the 
specific needs of the patient (disease-specific; 
age-, gender-, and lifestyle-specific; community-
specific).  
 
Disparate Data: The Example of 
Heart Failure 
This need to individualize the management of 
chronic illness becomes even more acute when 
one considers the origin of the guidelines upon 
which most interventions are based: medicine’s 
gold standard — randomized controlled trials. 
Despite recent efforts to the contrary, most 
randomized controlled trials under-represent the 
very people who suffer from health disparities, 
so it is not clear whether the treatment 
guidelines derived from them are valid for 
underserved patients (Bartlett, Doyal, & 
Ebrahim, 2005). Yet, the management of chronic 
conditions continues to be based upon guidelines 
derived from those data, perhaps because there 
does not appear to be an alternative. 
 
Finally, there is the issue of what to measure. 
The management of chronic disease is highly 
data-dependent, and yet sometimes it is not clear 
which data should be monitored. For example, 
frequent occurrences of decompensated 
congestive heart failure (CHF), which can be 
caused by several different factors, are a 
significant challenge in the outpatient treatment 
of CHF patients. Once patients with CHF 
undergo decompensation, CHF requires 
movement of clinical management from the 
outpatient to the more-costly emergency center 
or inpatient hospital setting, with the inevitable 
disruption to the patient and family. However, 
most CHF decompensation episodes are 
preceded by changes in vital signs in the 
previous days that, if detected early, might have 
led to self-care or intervention while the patient 
was at home and avoided a hospital readmission. 
In fact, studies have shown that home-
monitoring with self-reported or electronically 
transmitted daily measurements of vital signs 
(usually weight, blood pressure, heart rate, and 
oxygen saturation level) has the potential to 
reduce hospital admissions and improve patient 
satisfaction (Joseph, 2006). 
 
Unfortunately, as indicated by their limited 
enrollment under the auspices of research 
programs at academic medical centers, remote 
monitoring programs as currently implemented 
are labor intensive and costly, dependent on 
highly trained clinical personnel. Thus remote 
monitoring for CHF in underserved populations 
will remain economically infeasible until it is 
possible to determine exactly which patients will 
benefit under which circumstances. 
 
Patient responses to treatment tend to be 
indiosyncratic. There is no single number for 
any of the vital signs usually measured by CHF 
remote monitoring studies that can be clearly 
associated with decompensation for every 
patient. Instead, each patient’s record is a time-
course of events, some of them repeated, others 
of which are measured by multiple 
measurements or are simply errors. The data 
collected for each patient are multileveled, and 
their distribution, whose parameters must be 
estimated, will have a multidimensional 
structure. 
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Possible Solutions 
Together, the issue of under-represented 
populations in clinical trials and the example of 
CHF illustrate one of the largest obstacles facing 
management of chronic disease in underserved 
populations: the uncertainty involved in 
interpretation and individualization of the 
available data. We propose two possible 
solutions. One supplement to averages of data 
from clinical trials and multidimensional data 
from individuals is the concept of “personal 
normal.” A “personal normal” is a value that 
reflects the normal situation for that particular 
patient (which may not be the “norm” for any 
other person, or the one from the medical 
literature). However, deviation from this 
personalized normal, derived from the patient 
him or herself, over time, may be a better 
indicator of the patient’s true condition than a 
“standardized” normal or reams of 
undifferentiated measurements. 
 
Another method for overcoming the gaps in the 
data available for the management of chronic 
disease in underserved communities is the use of 
info-gap decision theory (Ben-Haim, 2006). 
Info-gap decision theory uncouples the 
distribution of data from probability theory, 
allowing patients and physicians to make robust 
decisions even when the data available are 
sparse or incomplete, or severely uncertain. The 
mathematical application of info-gap can be 
done real-time, and the resulting individualized 
recommendations served up to patients and their 
physicians quickly and in a form that is easy for 
patients to understand. 
 
Distributed (Point of Care) Health Care 
The first objective of the “19th National 
Conference on Chronic Disease Prevention and 
Control (NCCDPHP, 2005): Health Disparities” 
was to “engage people more directly where they 
live, work, and play, and encourage them to do 
what they can to protect and preserve their 
health and the health of those they care about” 
(National Center for Chronic Disease Prevention 
and Health Promotion, 2005). This objective 
reflects a fundamental truth about chronic 
disease: chronic disease is managed in the home, 
not treated in a doctor’s office. Distributed 
health care — health care delivered to patients 
where and when they need it — keeps the 
management of chronic disease in the homes and 
in the hands of patients themselves. 
 
An important insight from the literature on 
health disparities is that patients can be 
empowered by their communities. When 
healthcare is delivered to patients by people they 
trust, in a place where they feel comfortable, 
patients are better able to understand and 
participate in the health management process 
(Trans-HHS Cancer Health Disparities Progress 
Review Group, 2004, pp. 11-12). Patients with 
chronic illness are responsible for their own 
health in ways that few acute patients are, and 
successful management ultimately depends upon 
empowering them (Von Korff, Gruman, 
Schaefer, Curry, & Wagner, 1997). Delivering 
healthcare to patients where they live is an 
important step toward that goal. 
 
What most patients lack, however, and what 
underserved patients lack even more frequently, 
is the authority and information to match their 
responsibility (Trans-HHS Cancer Health 
Disparities Progress Review Group, 2004, pp. 
11-12). The following section describes a 
pathway that we are taking to resolve this 
problem and give chronic disease patients the 
authority and information support to manage 
their health in their homes and communities. 
 
Pathway to a Solution 
The key to effective care of chronic illness is 
management of the underlying condition to 
prevent acute episodes. However, such 
management is dependent upon empowered 
patients receiving timely, accurate data that they 
understand. In order to manage their conditions, 
chronic disease patients need careful, 
longitudinal monitoring with real-time feedback 
that they can trust and use. This feedback also 
needs to be available to them wherever they are. 
One approach to providing feedback to 
underserved patients is the distribution of 
inexpensive but effective biosensors to monitor 
a parameter of a chronic illness. 
 
Such a sensor is a biomedical measurement 
device designed to capture data through non-
invasive monitoring, perform analysis and 
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interpretation of the data using info-gap decision 
theory or simple linear analysis when 
appropriate, and provide guided intervention 
including communication with a health 
professional when individuals exceed their 
“personal normal” range. 
 
A biosensor can be designed for ease of use, 
accuracy, and low cost. Unlike top-down disease 
management models, which are expensive to 
implement and externally directed, the 
distributed health care approach begins and ends 
with individuals in their communities. By 
incorporating individualized medicine, personal 
normals, distributed health care, and community 
health workers, a biosensor empowers chronic 
illness patients with the authority, support, and 
information they need to manage their illnesses 
and minimize emergency room visits, 
hospitalizations, and complications. 
 
Barriers to Implementation 
How data are collected and communicated to the 
individual to make them useful to patients and 
their families is the user-interface challenge of 
the CHF biosensor model discussed above. The 
biosensor itself and the transmission of data are 
the engineering challenges. 
 
Also important is the societal issue of the 
diffusion of technology, particularly in 
underserved communities. An electronic device 
can hold meanings for its intended users that 
prevent them from employing it. For example, 
undocumented immigrants in the United States 
might refuse a remote heart monitor because 
they are concerned about being watched or 
tracked by the government. In fact, most 
communities and the individuals within them 
have concerns about trust and confidence in 
health care technology. These concerns often 
take two forms: (1) Can I believe the 
information emanating from the device? (2) Can 
I trust the person who is promoting it? These 
issues need to be addressed in a culturally 
competent manner prior to introducing a 
distributed health program that relies upon 
technology (Johnston, Wheeler, Deuser, & 
Sousa, 2000). 
 
In addition, it is tempting, as researchers, to 
define people as belonging to communities 
without verifying that such a bond exists (Oakes, 
2004). Often, this assumption is justified; but 
occasionally it is pernicious and dismissive. The 
well-structured distributed health program takes 
into account the autonomy and authority of the 
individual as well as the role of the community 
or neighborhood in which he or she lives before 
seeking to augment his or her efficacy with a 
technological or communications intervention. 
 
Cost is sometimes held out as a barrier to the 
implementation in underserved communities of a 
distributed health care system such as we 
propose. The “giant killer” question often posed 
is “who is going to pay for it?” In the face of a 
coordinated health care system, this question 
would not arise because there would be obvious 
savings to the “system.” In the fragmented and 
multi-tiered system extant in the United States, 
the answer is less obvious and may vary by 
locale. Closed systems such as Kaiser 
Permanente and the Department of Veterans 
Affairs are pioneers in distributed health because 
individual cost reverberates through the system. 
In the absence of an integrated health system, 
the cost has to be born by the party that suffers 
the most financially from unmanaged chronic 
conditions. This may be the hospital trying to 
bar early readmissions, the insurer trying to 
decrease utilization and payouts, the government 
seeking to conserve Medicare or Medicaid 
dollars or, even, in rare cases, the individual 
seeing a cost benefit to minimizing the 
frequency of encounters with the institutions of 
health care. 
 
A similar argument is often raised that the 
“doctors” will not accept the introduction of 
remote monitoring system for patients. This also 
flies in the face of reason. What irks physicians 
is not that people with illness take on the 
authority of self-management. Rather the 
physician simply cannot shoulder the 
accountability for decisions that he or she does 
not make. In a distributed health care model, the 
physician can be responsible for providing the 
diagnosis and the overall direction for treatment 
as well as for setting the context of treatment 
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(ideally by a community health worker who has 
formed a relationship with the patient). 
 
In this model, the physician provides a 
mechanism for recourse should people desire 
more structure or consultation. Dispersal of 
authority matched to accountability puts people 
on a course to making informed judgments about 
their own health and requiring the physician 
only for high-value questions where the doctor 
can exercise professional judgment. This “best 
use” of their time should increase physicians’ 
satisfaction and effectiveness. 
 
Conclusion 
The challenge of eliminating disparities in 
chronic illness in the United States requires 
understanding and addressing the complexity 
and variety of chronic conditions themselves, 
and of the communities and individuals affected 
by them. Most importantly, however, it requires 
empowering and supporting patients and their 
families to manage the illnesses effectively. This 
article outlined some of the ways in which those 
complexities manifest themselves in the data and 
the strategies available to clinicians and patients 
as they struggle to control chronic illness. We 
then used the example of chronic heart failure to 
illustrate a possible solution that we are 
developing: individualized health care through 
“personal normals” derived from the patient’s 
own clinical history analyzed by info-gap, and 
distributed health care (point of care through 
wireless biosensors and community health 
workers). In conclusion, we examined some of 
the possible barriers to the implementation of 
this model. Further research is necessary to test 
the clinical viability of the model and the 
acceptability of the sensor for underserved 
patients and their families and physicians. 
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